Stage-specifically expressed schistosome proteins as potential chemotherapeutic targets

Medical Science Monitor

Volumn 11, Issue 3, 2005, Pages

  El Ansary, Afaf ^a   Al Dalhan, Soad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adult worms; Cercarial penetration; Chemotheraputic targets; Miracidial infection; Protein expression; Schistosomes

Indexed keywords

ANTISCHISTOSOMAL AGENT; CALCIUM BINDING PROTEIN; CYCLOSPORIN A; PEROXIREDOXIN; PROTEIN 14 3 3; SCHISTOSOMA MANSONI RECEPTOR KINASE 1; THIOREDOXIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ADAPTATION; GENE EXPRESSION; IMMUNE RESPONSE; INTERMEDIATE HOST; LIFE CYCLE; MOLLUSC; NONHUMAN; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; TREMATODE;

ANIMALS; HELMINTH PROTEINS; HOST-PARASITE RELATIONS; HUMANS; LIFE CYCLE STAGES; MODELS, BIOLOGICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SCHISTOSOMICIDES;

EID: 15944362718     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Savioli L, renganathan A, Montresor A et al: Control of schistosomiasis - A global picture. Parasitol Today, 1979; 13: 444-48
2. Hoffman KF, Davis EM, Fisher ER, Wynn TA: The guanine protein coupled receptor rhodopsin is developmentally regulated in the free-living stages of Schistosoma mansoni. Molec Biochem Parasitol, 2001; 112: 113-23
3. Valle C, Festucci A, Calogero A et al: Stage-specific expression of Schistosoma mansoni polypeptide similar to venebrate regulatory protein stathmin. J Biol Chem, 1999; 274: 33869-74
4. Cioli D: Praziquantel: is there real resistance and are there alternatives? Curr Opin Infect Dis, 2000; 13: 659-63
5. Camus D, Zalis MG, Vannier-Santos MA, Banic DM: The art of parasite survival. Braz J Med Biol Res, 1995; 28: 399-413
6. Yoshino TP, Lodes MJ, Rege AA, Chappell CL: Proteinase activity in miracidia, transformation excretory-secretory products and primary sporocysts of Schistosoma mansoni. J Parasitol, 1993; 79: 23-31
7. Wippersteg V, Kapp K, Kunz W, Grevelding CG: Characterization of cysteine protease ER60 in transgenic Schistosoma mansoni larvae. Int J Parasitol, 2002; 32(100): 1219-24
8. Fire A: RNA-triggered gene silencing. Trends Genet, 1999; 15: 358-63
9. Britton C, Redmond DL, Knox DP et al: Identification of promoter elements of parasite nematode genes in transgenic Caenorhabditis elegant. Mol Biochem Parasitol, 1999; 103: 171-81
10. Mason PR, Fripp PJ: The reactions of Schistosoma mansoni miracidia to light. J Parasitol, 1977; 63: 240-44
11. Giant B, Martin-Barbey C, Curmi PA et al: The stathmin-tubulin interaction and the regulation of the microtubule assembly. Pathol Biol, 2003; 51(1): 33-38
12. Vicogne J, Pin JP, Lardans V et al: An unusual receptor tyrosine kinase of Schistosoma mansoni contains a venus flytrap module. Mol Biochem Parasitol, 2003; 126(1): 51-62
13. Ram D, Lantner F, Ziv E et al: Cloning of the Sm SPO-1 gene preferentially expressed in sporocyst during the life cycle of the parasite helminth Schistosoma mansoni. Biochemica et Biophysica Acta, 1999; 1453: 412-16
14. Ivanchenko MG, Lerner JP, McCormick RS et al: Continuous in vitro propagation and differentiation of cultures of the intramolluscan stages of the human parasite Schistosoma mansoni. Natl Acad Sci USA, 1999; 96 (9): 4965-70
15. Dalton JP, Clough KA, Jones MK, Brindley PJ: The cysteine proteinases of Schistosoma mansoni cercariae. Parasitology, 1997; 114: 105-12
16. Darani HY, Curtis RHC, McNeice C et al: Schistosoma mansoni: anomalous immunogenic properties of a 27-kDa larval serine protease associated with protective immunity. Parasitology, 1997; 115: 237-47
17. Pierrot C, Godin C, Liu JL et al: Schistosoma mansoni elastase: an immune target regulated during the parasite life-cycle. Parasitology, 1996; 113: 519-26
18. Ram D, Grossman A, Markovics A, Avivi E et al: Rapid changes in the expression of a gene encoding a calcium-binding protein in Schistosoma mansoni. Mol Biochem Parasitol, 1989; 34: 167-76
19. Goodman M, Pechere JF, Haiech J, Demaille G: Evolutionary diversification of structure and function in the family of intracellular calcium-binding proteins. J Mol Evol, 1979; 13: 331-52
20. Ram D, Ziv E, Lantner F, Schechter I: Interaction of the proteasome S 5a/Rpn 10-multiubiauitin-binding protein and the 8KDa calcium-binding protein of Schistosoma mansoni. Parasitology, 2003; 127(4): 337-47
21. Modha J, Redman CA, Thornhill JA, Kusel JR: Schistosomes: Unanswered questions on the basic biology of the host-parasite relationship. Parasitol Today, 1998; 14: 396-401
22. Hamdan FE, Ribeiro P. Characterization of a stable form of tryptophan hydroxylase from the human parasite Schistosoma mansoni. J. Biol. Chem. 1999; 274: 21746-57.
23. Mettrick DF: The role of 5-hydroxytryptamine (5-HT; serotonin) in glucose transport, intermediary carbohydrate metabolism and helminthes neurobiology. In: Bennet M, Behm C, Bryant C, editors, Comparative Biochemistry of Parasitic helminthes. Chapman and Hall, London, New York, 13-24
24. Salter JP, Chong Lim K, Hansell E et al: Schistosome invasion of human skin and degradation of dermal elastin are mediated by a single serine protease. J Biol Chem, 2000; 275: 38667-73
25. Skelly PJ, Shoemaker CB: Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni. Proc Nat Acad Sci USA, 1996; 96: 3642-46
26. Meyer F, Meyer H, Bueding E: Lipid metabolism in the parasite and free-living flat worms, Schistosoma mansoni and Dugesia dorotocephala. Biochemica et Biophysica Acta, 1970; 210: 256-66
27. Tendler M, Brito CFA, Serra-Freire N et al: Evidence from molecular modeling and experimental immunization that a Schistosoma mansoni fatty acid binding protein Sm14 is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA, 1996; 92: 269-73
28. Moser D, Tendler M, Griffiths G, Klinkert MQ. A 14-KD Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J Biol Chem, 1991; 266: 8447-54
29. Kaikaus RM, Bass NM, Ockner RK: Functions of the fatty acid binding proteins. Experientia, 1990; 46: 617-30
30. Glatz JF, Van der Vusse GJ: Nomenclature of fatty acid binding proteins. Mol Cell Biochem, 1990; 98: 231-35
31. Becker MM, Kalinna BH, Waine GJ, McManus DP: Gene cloning, over-production and purification of a functionally active cytoplasmic fatty acid-binding protein from the human blood fluke Schistosoma japonica. Gene, 1994; 148: 321-25
32. Scott JC, Kennedy MW, McManus DP: Molecular and immunological characterisation of a polymorphic cytosolic fatty acid binding protein from the human blood fluke of humans, Schistosoma japonicum. Biochem Biophys Acta, 2000; 1517: 53-62
33. Veerkamp JH, Van Moerkerk HT, Prinsen CF, van Kuppevett TH: Structural and functional studies on different human FABP types. Mol Cell Biochem, 1999; 192: 137-42
34. Brito CFA, Oliveira GC, Oliveira SC et al: Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm. Braz J Med Biol Res, 2002; 35(3): 377-81
35. LoVerde PT: Do antioxidants play a role in schistosome host-parasite interaction? Parasitol Today, 1998; 14: 285-89
36. Mei H, LoVerde PP. Schistosoma mansoni. the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol, 1997; 86: 69-78
37. Kwatia MA, Botkin DJ, Williams DL: Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin peroxidase. J Parasitol, 2000; 86: 908-15
38. McGonigle S, Dalton JP, James ER: Peroxidase: a new antioxidant family? Parasitol Today, 1998; 14: 139-45
39. Wood ZA, Schroder E, Harris JR, Poole LB: Structure, mechanism and regulation of peroxiredoxins Trends in Biochem Sciences, 2003; 28: 32-40
40. Alger HM, Saved AA, Stadecker MJ, Williams DL: Molecular and enzymatic characterization of Schistosoma mansoni thioredoxin. Int J Parasitol, 2002; 32(10): 1285-92
41. Williams DL, Asahi H, Botkin DJ, Stadecker MJ: Schistosoma infection stimulates host CD4+ T helper cell and B cell responses against a novel egg antigen, thioredoxin peroxidase. Infect Immun, 2001; 96: 1134-41
42. Amer ESJ, Holmgren A: Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 2000; 267: 6102-9
43. Sun QA, Kirnarsky L, Sherman S, Gladyshev VN: Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione system. Proc Natl Acad Sci USA, 2001; 98: 4673-78
44. Alger HM, Williams DL: The disulfide redox system of Schistosoma mansoni and the importance of multifunctional enzyme, thioredoxin glutathione reductase. Mol Biochem Parasitol, 2002; 121: 129-39
45. Hill KE, McCollum GW, Boeglin ME, Burk RF: Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun, 1997; 234: 293-95
46. Gromer S, Arscott LD, Williams CH et al: Human placenta thioredoxin reductase. J Biol Chem, 1998; 273: 20096-101
47. Bostic JR, Strand M: Molecular cloning of a Schistosoma mansoni protein expressed in the gynecophoral canal of male worms. Mol Biochem Parasitol, 1996; 79(1): 79-89
48. Chlichlia K, Bahgat M, Ruppel A, Schirrmacher V: DNA vaccination with asparaginyl endopeptidase (sm 32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine, 2001; 20: 439-47
49. Aitken A, Collinge DB, van Heusden BP et al: 14-3-3 and its possible role in coordinating multiple signaling pathways. Trends Cell Biol, 1996; 6: 341-47
50. Fu H, Romesh R, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol, 2000; 40: 617-47
51. Schechtman D, Ram D, Tarrab-Hazdai R et al: Stage-specific expression of the mRNA encoding a 14-3-3 protein during the life cycle of Schistosoma mansoni. Mol Biochem Parasitol, 1995; 73: 275-78
52. McGonigle S, Beall MJ, Feeney EL, Pearce EJ: Conserved role for 14-3-3ε downstream of type I TGFB receptors. FEBS Lett, 2001; 490: 65-69
53. McGonigle S, Loschiavo M, Pearce EJ: 14-3-3 proteins in identification of a second epsilon isoform. Int J Parasitol, 2002; 32: 685-93
54. Schechtman D, Tarrab-Hazadi R, Amon R: The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol, 2001; 23: 213-17
55. Ngaiza JR, Doenhoff MJ, Jaffe EA: Schistosoma mansoni egg attachment to cultured human umbilical vein endothelial cells: an In Vitro model of an early step of parasite egg excretion. J Infect Dis, 1993; 168: 1576-80
56. Loeffler DA, Lundy SK, Singh KP et al: Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. Parasitology, 1996; 112: 199-204
57. + T helper cell response to the dominant epitop of major egg antigen Sm 40. Exp Parasitol, 1998; 90: 122-30
58. + T helper cell response in the C57BL/6 mouse. Infec Immun, 1999; 67: 1729-35
59. Stadecher MJ, Hernandez HJ: The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40. Parasite Immunol, 1998; 20(5): 217-21
60. Cummings RD, Nyame AK: Schistosome glycoconjugates. Biochem Biophys Acta, 1999; 1455: 363-74
61. Damian RT: The exploitation of host immune responses by parasites. J Parasitol, 1987; 73: 3-13
62. st century. Science, 2001; 293: 1437-38
63. Brindley PJ, Laha, T, McManus DP, Loukas A: Mobile genetic elements colonizing the genomes of metazoan parasites. Trends Parasitol, 2003; 19: 79-87
64. Trap C, Bioreau P: Proteases in helminthic parasites. Vet Res, 2000; 31(5): 461-65
65. Doenhoff MJ: A vaccine for schistosomiasis: alternative approaches. Parasitol Today, 1998; 14: 105-9
66. Lim KC, Sun E, Bahgat M: Blockage of skin invasion by schistosome cercariae by serine protease inhibitors. Am J Trop Med Hyg, 1999; 60: 487-92
67. Wasilewski MM, Lim KC, Phillips J, McKerrow JH: Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivi. Molec Biochem Parasitol, 1996; 81: 179-89
68. Rao KVN, Chen L, Gnanasekar M, Ramaswamy K: Cloning and characterization of calcium-binding, Histamine-releasing protein from schistosoma mansoni. J Biol Chem, 2002; 277: 31207-213
69. Ercoli N, Payares G, Nunez D: Schistosoma mansoni: neurotransmittors and mobility of cercaria and schistosomules. Exp Parasitol, 1985; 59: 204-16
70. Hamdan FF, Abramovitz M, Mousa A et al: A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Molec Biochem Parasitol, 2002; 119: 75-86
71. Serra EC, Lardans V, Dissous C: Identification of NF-AT-like transcription factor in Schistosoma mansoni its possible involvement in the antiparasitic action of cyclosporine A. Molec Biochem Parasitol, 1999; 101: 33-41
72. Davies SJ, Pearce EJ: A typical post-translational modification and targeting of a schistosoma mansoni sur face receptor, a member of the transforming growth factor β receptor family of cell surface receptors. Molec Biochem Parasitol, 1999; 104: 299-310
73. Jin DY, Jeang KT: Peroxiredoxins in cell signaling and HIV infection. In: Antioxidant and Redox Regulations of genes (Sen CK et al. eds) Academic Press, 2000; 381-107
74. Fujii J, Ikeda Y: Advances in our understanding of Peroxiredoxins, a multifunctional, mammalian redox protein. Redox Rep, 2002; 7: 123-30